Heart Test Laboratories up on receiving Korean patent for heart device
** Shares of medical device maker Heart Test Laboratories
Inc HSCS.O jump 80% to $2.58, among biggest pct. gainers on
U.S. stock exchanges
** Company says it was granted Korean patent for its heart
device that detects irregular heartbeat and structural heart
disease at an early stage
** HSCS says to date, it has been granted nine U.S. patents,
and 30 international patents for its heart devices
** Stock lost ~41% since IPO in June last year
(Reporting by Khushi Mandowara in Bengaluru)
((Khushi.Mandowara@thomsonreuters.com))
Recent news on HeartSciences
See all newsBrief: Heartsciences Files Definitive Proxy Statement For Proposed Business Combination With Fortitude Mining
Brief: Fortitude Provides Second Quarter 2026 Financial And Operating Highlights
Brief: Fortitude Invests $1.0 Million In Heartsciences At A 22% Premium With No Adjustment To The Merger Consideration
Brief: Heartsciences - Files Preliminary Proxy For Business Combination With Fortitude Mining Holdings
Brief: Heartsciences Signs First Saas Revenues Agreement Following Full Launch Of Myovista Insights™